These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27429849)

  • 1. Peroxisome proliferator-activated receptor-γ agonist inhibits collagen synthesis in human keloid fibroblasts by suppression of early growth response-1 expression through upregulation of miR-543 expression.
    Zhu HY; Bai WD; Wang HT; Xie ST; Tao K; Su LL; Liu JQ; Yang XK; Li J; Wang YC; He T; Han JT; Hu DH
    Am J Cancer Res; 2016; 6(6):1358-70. PubMed ID: 27429849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-γ agonist troglitazone suppresses transforming growth factor-β1 signalling through miR-92b upregulation-inhibited Axl expression in human keloid fibroblasts in vitro.
    Zhu HY; Bai WD; Li J; Tao K; Wang HT; Yang XK; Liu JQ; Wang YC; He T; Xie ST; Hu DH
    Am J Transl Res; 2016; 8(8):3460-70. PubMed ID: 27648136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen synthesis in human hypertrophic scar fibroblasts by targeting Smad3 via miR-145.
    Zhu HY; Li C; Zheng Z; Zhou Q; Guan H; Su LL; Han JT; Zhu XX; Wang SY; Li J; Hu DH
    Biochem Biophys Res Commun; 2015 Mar; 459(1):49-53. PubMed ID: 25704091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
    Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
    Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-203 regulates keloid fibroblast proliferation, invasion, and extracellular matrix expression by targeting EGR1 and FGF2.
    Shi K; Qiu X; Zheng W; Yan D; Peng W
    Biomed Pharmacother; 2018 Dec; 108():1282-1288. PubMed ID: 30372829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of miR-23b-3p Ameliorates Scar-Like Phenotypes of Keloid Fibroblasts by Facilitating A20 Expression.
    Kuai Q; Jian X
    Clin Cosmet Investig Dermatol; 2022; 15():1549-1559. PubMed ID: 35967914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.
    Li Y; Wen X; Spataro BC; Hu K; Dai C; Liu Y
    J Am Soc Nephrol; 2006 Jan; 17(1):54-65. PubMed ID: 16291834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
    Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of IRF3 inhibits extracellular matrix expression in keloid fibroblasts.
    Zhang Y; Zhang L; Lin XH; Li ZM; Zhang QY
    Biomed Pharmacother; 2017 Apr; 88():1064-1068. PubMed ID: 28192879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
    Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro.
    Routh RE; Johnson JH; McCarthy KJ
    Kidney Int; 2002 Apr; 61(4):1365-76. PubMed ID: 11918743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EXPRESSION AND SIGNIFICANCE OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR γ IN KELOID].
    Lei L; Deng Y; Chen J; Cen Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Sep; 30(9):1143-1145. PubMed ID: 29786372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes.
    Li Y; Shen Y; Li M; Su D; Xu W; Liang X; Li R
    Mol Cell Biochem; 2015 Jul; 405(1-2):233-41. PubMed ID: 25920446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids.
    Lee WJ; Ahn HM; Roh H; Na Y; Choi IK; Lee JH; Kim YO; Lew DH; Yun CO
    Exp Dermatol; 2015 Aug; 24(8):591-7. PubMed ID: 25865370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
    J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts.
    Hasegawa T; Nakao A; Sumiyoshi K; Tsuboi R; Ogawa H
    J Dermatol Sci; 2003 Jun; 32(1):19-24. PubMed ID: 12788525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs.
    Li C; Bai Y; Liu H; Zuo X; Yao H; Xu Y; Cao M
    Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):692-9. PubMed ID: 23709205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
    Camp HS; Li O; Wise SC; Hong YH; Frankowski CL; Shen X; Vanbogelen R; Leff T
    Diabetes; 2000 Apr; 49(4):539-47. PubMed ID: 10871190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.